🇺🇸 FDA

Intelligence Platform

Patents

Browse 6 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11667702

Stable aqueous formulations of aflibercept

Coherus BioSciences, Inc. · Granted Tue Jun 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11535663

Methods for producing aflibercept in chemically defined media having reduced aflibercept v

REGENERON PHARMACEUTICALS, INC. · Granted Tue Dec 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11472861

Methods for producing aflibercept in chemically defined media having reduced aflibercept v

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11426446

Stable aqueous formulations of aflibercept

Coherus BioSciences, Inc. · Granted Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11104715

Methods for producing aflibercept in chemically defined media having reduced aflibercept v

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11071780

Methods and formulations for treating vascular eye diseases using aflibercept and nesvacum

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jul 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted